Kevin Young, EVP, Commercial Operations at GILEAD SCIENCES INC (GILD), sold 75,000 shares at $69.20 ($5.1M) on 2013-10-23, disclosed to the SEC on 2013-10-25.
Scheduled sale ($5.1M) by EVP, Commercial Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.54 | 72,500 | $5.0M | 96.6% |
| 2 | $69.20 | 2,500 | $173K | 3.4% |
| Total | $68.56 avg | 75,000 | $5.1M | 100% |
| Filing → |
| GILD | SELL | 2013-12-24 | $5.6M | — | Filing → |
| GILD | SELL | 2013-11-25 | $5.6M | — | Filing → |
| GILD | SELL | 2013-09-25 | $6.3M | — | Filing → |